Dr Qasim Rafiq is an Associate Professor at University College London in Cell and Gene Therapy Bioprocessing. He is a multidisciplinary engineer working at the life science, engineering and commercial interfaces and his research focuses on the bioprocessing, automation and biomanufacture of ATMPs.
He currently leads a research portfolio of >3.5m and heads up the Cell and Gene Therapy Bioprocess Engineering group at UCL which includes 4 post-doctoral researchers and 7 PhD students. He is also Programme Director of a new Masters programme which is launching in September 2020 entitled Manufacture and Commercialisation of Stem Cell and Gene Therapies.
He is both a Chartered Engineer (CEng) and Chartered Scientist (CSci) and sits on multiple scientific and engineering committees including the British Standards Institute (BSI) Biotechnology Committee, the IChemE Biochemical Engineering Subject Interest Group and the BIAs Cell and Gene Therapy Advisory Committee.